Daniel D Langleben MD
Addiction
Associate Professor, Psychiatry, Perelman School of Medicine
Join to View Full Profile
3535 Market StPhiladelphia, PA 19104
Phone+1 215-746-6700
Are you Dr. Langleben?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Daniel Langleben, MD is a board certified psychiatrist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, New Jersey, and West Virginia. He is an Associate Professor at Perelman School of Medicine.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Nuclear Medicine, 1997 - 1999
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Radiology-Diagnostic, 1993 - 1995- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Psychiatry, 1991 - 1993
Drexel University College of Medicine/Hahnemann UniversityInternship, Transitional Year, 1990 - 1991
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1988
Certifications & Licensure
CA State Medical License 1996 - 2026
PA State Medical License 1999 - 2026
WV State Medical License 2019 - 2026- PA State Medical License 1990 - 2024
NJ State Medical License 2020 - 2021
NY State Medical License 1993 - 1997
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Addiction Psychiatry
Publications & Presentations
PubMed
- 1 citationsMedial prefrontal neuroplasticity during extended-release naltrexone treatment of opioid use disorder - a longitudinal structural magnetic resonance imaging study.Zhenhao Shi, Xinyi Li, Dustin R Todaro, Wen Cao, Kevin G Lynch
Translational Psychiatry. 2024-09-05 - Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity.Zhenhao Shi, Daniel D Langleben, David Rott, Mark Albanese, Igor Elman
Journal of Addictive Diseases. 2024-03-31 - Collateral Damage: Neurological Correlates of Non-Fatal Overdose in the Era of Fentanyl-Xylazine.Dustin R Todaro, Nora D Volkow, Daniel D Langleben, Zhenhao Shi, Corinde E Wiers
Neuroscience Insights. 2024-01-01
Press Mentions
Is This Proof Brain Scans Can Read Our Minds? Special Type of MRI Translated Brainwaves into ImagesAugust 23rd, 2022
Could Brain Scans Determine Guilt or Innocence in Court?November 10th, 2017
The Problem of Lie DetectionNovember 15th, 2016- Join now to see all
